IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v514y2014i7524d10.1038_nature13611.html
   My bibliography  Save this article

Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function

Author

Listed:
  • Andrea Viale

    (The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center)

  • Piergiorgio Pettazzoni

    (The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center)

  • Costas A. Lyssiotis

    (Weill Cornell Medical College)

  • Haoqiang Ying

    (The University of Texas MD Anderson Cancer Center)

  • Nora Sánchez

    (The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center)

  • Matteo Marchesini

    (The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center)

  • Alessandro Carugo

    (The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center
    European Institute of Oncology, Milan 20139, Italy)

  • Tessa Green

    (The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center)

  • Sahil Seth

    (Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center)

  • Virginia Giuliani

    (Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center)

  • Maria Kost-Alimova

    (Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center)

  • Florian Muller

    (The University of Texas MD Anderson Cancer Center)

  • Simona Colla

    (The University of Texas MD Anderson Cancer Center)

  • Luigi Nezi

    (The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center)

  • Giannicola Genovese

    (The University of Texas MD Anderson Cancer Center)

  • Angela K. Deem

    (The University of Texas MD Anderson Cancer Center)

  • Avnish Kapoor

    (The University of Texas MD Anderson Cancer Center)

  • Wantong Yao

    (The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center)

  • Emanuela Brunetto

    (Pathology Unit, San Raffaele Scientific Institute, Milan 20132, Italy)

  • Ya’an Kang

    (The University of Texas MD Anderson Cancer Center)

  • Min Yuan

    (Beth Israel Deaconess Medical Center)

  • John M. Asara

    (Beth Israel Deaconess Medical Center)

  • Y. Alan Wang

    (The University of Texas MD Anderson Cancer Center)

  • Timothy P. Heffernan

    (Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center)

  • Alec C. Kimmelman

    (Dana-Farber Cancer Institute)

  • Huamin Wang

    (The University of Texas MD Anderson Cancer Center)

  • Jason B. Fleming

    (The University of Texas MD Anderson Cancer Center)

  • Lewis C. Cantley

    (Weill Cornell Medical College)

  • Ronald A. DePinho

    (The University of Texas MD Anderson Cancer Center)

  • Giulio F. Draetta

    (The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center)

Abstract

KRAS mutations are a driver event of pancreatic ductal adenocarcinoma; here, a subpopulation of dormant tumour cells, relying on oxidative phosphorylation for survival, is shown to be responsible for tumour relapse after treatment targeting the KRAS pathway.

Suggested Citation

  • Andrea Viale & Piergiorgio Pettazzoni & Costas A. Lyssiotis & Haoqiang Ying & Nora Sánchez & Matteo Marchesini & Alessandro Carugo & Tessa Green & Sahil Seth & Virginia Giuliani & Maria Kost-Alimova &, 2014. "Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function," Nature, Nature, vol. 514(7524), pages 628-632, October.
    • Handle: RePEc:nat:nature:v:514:y:2014:i:7524:d:10.1038_nature13611
    DOI: 10.1038/nature13611
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature13611
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature13611?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Shuaifeng Li & Shixun Han & Qi Zhang & Yibing Zhu & Haitao Zhang & Junli Wang & Yang Zhao & Jianhui Zhao & Lin Su & Li Li & Dawang Zhou & Cunqi Ye & Xin-Hua Feng & Tingbo Liang & Bin Zhao, 2022. "FUNDC2 promotes liver tumorigenesis by inhibiting MFN1-mediated mitochondrial fusion," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    2. Sarah Figarol & Célia Delahaye & Rémi Gence & Aurélia Doussine & Juan Pablo Cerapio & Mathylda Brachais & Claudine Tardy & Nicolas Béry & Raghda Asslan & Jacques Colinge & Jean-Philippe Villemin & Ant, 2024. "Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    3. Ziheng Chen & I-Lin Ho & Melinda Soeung & Er-Yen Yen & Jintan Liu & Liang Yan & Johnathon L. Rose & Sanjana Srinivasan & Shan Jiang & Q. Edward Chang & Ningping Feng & Jason P. Gay & Qi Wang & Jing Wa, 2023. "Ether phospholipids are required for mitochondrial reactive oxygen species homeostasis," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    4. Amr Khalifa & Ana Guijarro & Silvia Ravera & Nadia Bertola & Maria Pia Adorni & Bianca Papotti & Lizzia Raffaghello & Roberto Benelli & Pamela Becherini & Asmaa Namatalla & Daniela Verzola & Daniele R, 2023. "Cyclic fasting bolsters cholesterol biosynthesis inhibitors’ anticancer activity," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    5. Yuanli Zhen & Kai Liu & Lei Shi & Simran Shah & Qin Xu & Haley Ellis & Eranga R. Balasooriya & Johannes Kreuzer & Robert Morris & Albert S. Baldwin & Dejan Juric & Wilhelm Haas & Nabeel Bardeesy, 2024. "FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma," Nature Communications, Nature, vol. 15(1), pages 1-17, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:514:y:2014:i:7524:d:10.1038_nature13611. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.